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For cancer patients being faced with a dismal prognosis whether initially or during follow-up is frequently reason 
for a second opinion.1 We present a remarkable example of the 
benefits that a second opinion may provide.
CASE REPORT
A 46-year old woman received chemoradiotherapy 
with curative intent (first cycle cisplatinum 80 mg/m2 and 
pemetrexed 500 mg/m2; second and third cycles cisplatinum 
80 mg/m2  and etoposide 100 mg/m2 on days 1, 2, and 3, con-
current with thoracic radiotherapy 33 ×2 Gy and prophylactic 
cranial irradiation as part of the Nederlandse Vereniging van 
Artsen voor Longziekten en Tuberculose (NVALT)-11 trial) 
for stage IIIB adenocarcinoma of the right upper lobe. After 
9 months, she presented with dyspnoea, wheezing, and severe 
nonproductive cough. Positron emission tomography and com-
puted tomography scanning showed a cavitating lesion in the 
irradiated area in the right upper lobe and multiple fluorode-
oxyglucose-avid lesions in the right lung. These images were 
regarded as recurrent non–small-cell lung carcinoma, accom-
panied by an infectious component. For the latter, ciprofloxacin 
was given. The presumed diagnosis of tumor recurrence and the 
fatal prognosis were discussed with the patient and her husband. 
The step to seek a second opinion was initiated by the patient.
All data were reviewed and the computed tomog-
raphy scan repeated. The scan showed multiple nodules in 
both lungs, cavitation in the irradiated tumor area, and an 
increase of fibrosis and stricture of the upper lobe bronchus 
(Fig. 1). The positron emission tomography findings could be 
explained by an active infection in and around the cavitation 
without proven signs of tumor recurrence. Despite repeated 
antibiotic treatment, the situation deteriorated with continu-
ous cough, shortness of breath, weight loss, and anaemia. 
Laboratory findings showed a C-reactive protein of 257 mg/l 
and a normal white blood cell count (9.6 × 109/l). To drain 
the cavity, an open-window thoracostomy was performed and 
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necrotic tissue was removed (Fig. 2). Aspergillus fumigatus 
was isolated in the pathological specimen and the patient 
received postoperative antimicrobial and antifungal therapy. 
The patient’s cough disappeared immediately and her con-
dition improved considerably. Three months after thoracos-
tomy, the patient presented with bleeding from the cavity. 
After gauze tamponade, the serratus anterior muscle was 
transposited into the cavity (Fig. 3).The postoperative course 
was uneventful and 15 months after her initial visit for a 
FIGURE 1. Computed tomography scan at time of presen-
tation showing cavitation and multiple lesions.
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second opinion, there still are no signs of infection or recur-
rent tumor. The patient resumed work.
COMMENT
High-dose radiotherapy results in damage of the cir-
culation and may cause necrosis within the irradiated area.2,3 
Defence against infection will be limited and radiologi-
cal changes in this area might therefore be because of the 
effects of infection. Differential diagnosis between infection 
and tumor progression is extremely difficult, also because 
uptake of 18 fluorodeoxyglucose is present in both situations. 
Treatment of infected necrosis in an irradiated area is diffi-
cult.4 Surgical resection of the complete area is risky because 
of the scarring and patients usually present in a poor general 
condition. A less hazardous procedure to open the cavity and 
evacuate the necrotic and infected tissue is preferable.5 After 
initial improvement, muscle flaps can be used to fill the cavity 
with healthy tissue.
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FIGURE 2. Computed tomography scan after open-window 
thoracostomy with gauzes in situ.
FIGURE 3. Computed tomography scan after muscle plasty 
of the serratus anterior muscle in the cavity.
